Steven Girgenti - Jan 10, 2025 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Executive Chairman, Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Stock symbol
BIAF
Transactions as of
Jan 10, 2025
Transactions value $
$0
Form type
4
Date filed
1/14/2025, 04:15 PM
Previous filing
Jul 2, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +14.8K +1.39% $0.00 1.08M Jan 10, 2025 Direct F1
holding BIAF Common Stock 8.96K Jan 10, 2025 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025.
F2 These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.